PUBLIC COMPANY
saveEmory University
updated 5mo ago
Emory University is a private research university in Atlanta, Georgia, United States. It was founded in 1836 as Emory College by the Methodist Episcopal Church and named in honor of Methodist bishop John Emory. Its main campus is in Druid Hills, four miles from downtown Atlanta.
community read0 votes
🐶 often sniffed alongside
top 8- tagType 2 Diabetes2 co-mentions · 2 sources
- tagImmunology2 co-mentions · 2 sources
- tagHepatology2 co-mentions · 2 sources
- tagSickle Cell Disease2 co-mentions · 2 sources
- drugAlzheimer's Disease2 co-mentions · 2 sources
- tagAlzheimer's Disease2 co-mentions · 2 sources
- tagCardiology1 co-mentions · 1 sources
- tagOncology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
34
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade
- phase2Baricitinib Curative Repression of HIV-1
- phase1VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer
- phase1VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
- phase2Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- phase1Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
- phase2Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
- phase2Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
🐶 Hiring Signal
News
- In this hospital, pulse oximeters went from overestimating to underestimating blood oxygen. Why?Researchers found pulse oximeters went from overestimating blood oxygen levels to underestimating them; inaccuracies were worse in patients of color.stat · 1h ago
- FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancerIn a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, turning a contentious regulatory review into a landmark win that opens a new…fiercebiotech · 28d ago
- Opinion: It’s time to take the gloves off during vaccinationMost of the time, it’s unnecessary to use gloves to administer a flu shot, write Cassandra Thiel and Preeti Jaggi.stat · 28d ago
- A winner, a loser, and a mid-stage signal from a major cardiology research conferenceThe mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news from Morning Roundsstat · 1mo ago
- Nurse practitioner trainees find themselves stymied by shortage of clinical mentorsNurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.stat · 1mo ago
- Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hintExperts ask: How can we better reach out to people facing Medicaid renewal deadlines and support them through the paperwork requirements?stat · 1mo ago
- Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none existsCDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.stat · 3mo ago
- Opinion: The virtual end of the doctor’s office waiting roomIt’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.stat · 4mo ago
- Hantavirus risk remains low, CDC says, citing its ‘playbook’ responseDespite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low.stat · 4mo ago
- GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.onclive · 4mo ago
comments(0)
5-min edit window · permanent after that